MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$709,562
(8.80%↑ Y/Y)
Other comprehensive
income - foreign...
$433,586
(5668.84%↑ Y/Y)
Net loss
-$1,143,148
(-45.52%↓ Y/Y)
Loss before income
taxes
-$1,143,148
(-45.52%↓ Y/Y)
Revenue
$983,536
(-13.44%↓ Y/Y)
Loss from operations
-$1,117,264
(-47.28%↓ Y/Y)
Net other expense
-$25,884
(3.97%↑ Y/Y)
Gross profit (gain)
$285,487
(309.82%↑ Y/Y)
Interest income
$147
(-86.31%↓ Y/Y)
Cost of revenue
$698,049
(-45.14%↓ Y/Y)
Total operating
expenses
$1,402,751
(125.32%↑ Y/Y)
Interest expense
$26,031
(-7.13%↓ Y/Y)
Credit losses
-$2,881
(-117.76%↓ Y/Y)
General and
administrative expenses
$1,226,272
(141.78%↑ Y/Y)
Selling expenses
$95,598
(9.74%↑ Y/Y)
Research and development
expenses
$83,762
(183.10%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)